1Yoshida H,Shiratori Y, Moriyama M,et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med,1999,131(3): 174-81
2Mazzella, G, Accogli E, Sottili S, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV - related liver cirrhosis. J Hepatol, 1996,24(2): 141-7
3Lmai Y, Kawata S, Tamura S, et al. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med, 1998,129(2) :94-9
4Shindo M, Ken A and Okuno T. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Cancer, 1999,85(9): 1943-50
5Ikeda K, Satioh S, Suzuki Y, et al. Interferon decreases hepatocellular carcinogensis in patients with cirrhosis caused by the hepatitis B Virus: a pilot study. Cancer, 1998,82(5) :827-35
6Lin SM, Sheen IS, Chien RN, et al. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology,1999,29(3) :971-5
7Tamori A, Kuroki T, Nishiguchi S, et al. Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus. Hepatogastroenterology, 1996,43(10): 1079-83
